These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8486828)

  • 1. MR imaging advances in practice.
    Drayer BP
    J Comput Assist Tomogr; 1993; 17 Suppl 1():S30-5. PubMed ID: 8486828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS.
    Myhr G; Rinck PA; Børseth A
    Acta Radiol; 1992 Sep; 33(5):405-9. PubMed ID: 1389644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging contrast agents: theory and application to the central nervous system.
    Bronen RA; Sze G
    J Neurosurg; 1990 Dec; 73(6):820-39. PubMed ID: 2230966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadopentetate dimeglumine in craniospinal magnetic resonance imaging: common uses and some potential pitfalls.
    Hardjasudarma M
    Can Assoc Radiol J; 1992 Apr; 43(2):100-10. PubMed ID: 1562885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of contrast-enhanced MRI in the brain, head and neck: gadodiamide injection versus gadopentate dimeglumine.
    Sadni M; Collignon J; Dondelinger RF; De Greef D
    J Belge Radiol; 1997 Oct; 80(5):225-8. PubMed ID: 9400053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study.
    Svaland MG; Christensen T; Lundorf E
    Acta Radiol; 1994 Jul; 35(4):396-9. PubMed ID: 8011392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance contrast agents in neuroimaging. New agents and applications.
    Runge VM; Kirsch JE; Wells JW; Dunworth JN; Awh MH; Bittner DF
    Neuroimaging Clin N Am; 1994 Feb; 4(1):175-83. PubMed ID: 8130948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with gadolinium contrast agents in spinal MR imaging.
    Sze GK
    J Comput Assist Tomogr; 1993; 17 Suppl 1():S8-13. PubMed ID: 8486831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced MR imaging in neuroimaging.
    Kim BS; Gutierrez JE
    Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):649-85. PubMed ID: 23088944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging contrast agents.
    Runge VM
    Curr Opin Radiol; 1992 Feb; 4(1):3-12. PubMed ID: 1739599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging of the brain and spine. Is clinical efficacy established after the first decade?
    Kent DL; Larson EB
    Ann Intern Med; 1988 Mar; 108(3):402-24. PubMed ID: 3277514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal lesions: quantitative and qualitative temporal evolution of gadopentetate dimeglumine enhancement in MR imaging.
    Sze G; Bravo S; Krol G
    Radiology; 1989 Mar; 170(3 Pt 1):849-56. PubMed ID: 2916042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 1.0 M gadobutrol and 0.5 M gadopentetate dimeglumine-enhanced magnetic resonance imaging in five hundred seventy-two patients with known or suspected liver lesions: results of a multicenter, double-blind, interindividual, randomized clinical phase-III trial.
    Hammerstingl R; Adam G; Ayuso JR; Van Beers B; Belfiore G; Bellin MF; Bongartz G; Ernst O; Frericks B; Giuseppetti G; Heinz-Peer G; Laghi A; Martin J; Pering C; Reimer P; Richter GM; Roemer FW; Schäfer FK; Vilgrain V; Vogl TJ; Weishaupt D; Wall A; Zech CJ; Tombach B
    Invest Radiol; 2009 Mar; 44(3):168-76. PubMed ID: 19169143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children.
    Colosimo C; Demaerel P; Tortori-Donati P; Christophe C; Van Buchem M; Högström B; Pirovano G; Shen N; Kirchin MA; Spinazzi A
    Pediatr Radiol; 2005 May; 35(5):501-10. PubMed ID: 15678342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motion artifacts in brain and spine MR.
    Hinks RS; Quencer RM
    Radiol Clin North Am; 1988 Jul; 26(4):737-53. PubMed ID: 3289073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital heart disease: cardiovascular MR imaging by using an intravascular blood pool contrast agent.
    Makowski MR; Wiethoff AJ; Uribe S; Parish V; Botnar RM; Bell A; Kiesewetter C; Beerbaum P; Jansen CH; Razavi R; Schaeffter T; Greil GF
    Radiology; 2011 Sep; 260(3):680-8. PubMed ID: 21613441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine.
    Jensen MC; Brant-Zawadzki M
    AJR Am J Roentgenol; 1993 Jan; 160(1):153-7. PubMed ID: 8416615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III clinical studies with gadoteridol for the evaluation of neurologic pathology. A European perspective.
    Seiderer M
    Invest Radiol; 1992 Aug; 27 Suppl 1():S33-8. PubMed ID: 1506151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging of pituitary region lesions with gadodiamide injection.
    Hald JK; Skalpe IO; Bakke SJ; Nakstad PH
    Acta Radiol; 1994 Jan; 35(1):65-9. PubMed ID: 8305277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
    Vogl TJ; Mack MG; Juergens M; Stark M; Pegios W; Bergman C; Grevers G; Western A
    AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.